Shares of Granules India Ltd crashed 4% on 9 September after the company announced receiving six observations from the US Food and Drug Administration (USFDA). ...
Granules India shares were trading in the red and 1% lower on 13 December despite receiving approval from USFDA for its pantoprazole sodium delayed-release tablets....